Biora Therapeutics, Inc.
BIOR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $18,337 | $225,037,058 | $215,331 | $334,947 |
| - Cash | $3,196 | $5,325 | $10,820 | $15,211 |
| + Debt | $39,646 | $46,961 | $46,757 | $47,426 |
| Enterprise Value | $54,787 | $225,078,694 | $251,268 | $367,162 |
| Revenue | $32 | $318 | $542 | $872 |
| % Growth | -89.9% | -41.3% | -37.8% | – |
| Gross Profit | $32 | $208 | $542 | -$117 |
| % Margin | 100% | 65.4% | 100% | -13.4% |
| EBITDA | -$16,227 | $7,219 | -$1,279 | -$13,770 |
| % Margin | -50,709.4% | 2,270.1% | -236% | -1,579.1% |
| Net Income | -$18,402 | $6,465 | -$4,189 | -$15,413 |
| % Margin | -57,506.3% | 2,033% | -772.9% | -1,767.5% |
| EPS Diluted | -5.04 | 0 | -0.14 | -0.62 |
| % Growth | – | 100% | 77.4% | – |
| Operating Cash Flow | $31,823 | -$10,952 | -$12,496 | -$13,745 |
| Capital Expenditures | -$19 | -$180 | -$15 | -$66 |
| Free Cash Flow | $31,951 | -$11,132 | -$12,511 | -$13,811 |